Onsdag 15 Januari | 11:48:19 Europe / Stockholm
Svenska | English

Modulight

Bifogade filer

Kursutveckling under dagen för detta pressmeddelande (EUR).

Likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

Tid*
2025-10-24 12:00 Kvartalsrapport 2025-Q3
2025-08-22 12:00 Kvartalsrapport 2025-Q2
2025-05-02 N/A Årsstämma
2025-04-25 12:00 Kvartalsrapport 2025-Q1
2025-02-21 12:00 Bokslutskommuniké 2024
2024-10-18 - Kvartalsrapport 2024-Q3
2024-08-16 - Kvartalsrapport 2024-Q2
2024-05-06 - X-dag ordinarie utdelning MODU 0.00 EUR
2024-04-26 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2023-10-20 - 15-10 2023-Q3
2023-08-18 - Kvartalsrapport 2023-Q2
2023-05-03 - X-dag ordinarie utdelning MODU 0.00 EUR
2023-05-02 - Årsstämma
2023-04-28 - 15-10 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-08-19 - Kvartalsrapport 2022-Q2
2022-05-03 - X-dag ordinarie utdelning MODU 0.00 EUR
2022-05-02 - Årsstämma

Beskrivning

LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
Modulight är verksamt inom teknikbranschen. Bolaget designar, marknadsför och producerar biomedicinska laserprodukter som används inom onkologi, genetik och oftalmologi. Kunderna består primärt av sjukhus och företagskunder verksamma inom medicinteknik. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Störst verksamhet återfinns inom Europa.
Modulight’s Annual Report 2023 Published
2024-03-15 12:20:00

Modulight Corporation | Company Release | March 15, 2024 at 13:20:00 EET

Modulight’s Annual Report 2023 has been published today. The Annual Report includes the financial statements, the Board of Directors’ Report and sustainability information. In addition, Modulight has published the Corporate Governance Statement and the Remuneration Report. All materials have been published in Finnish and English.

The Annual Report, the Corporate Governance Statement and the Remuneration Report are attached to this release and available at https://modulight.com/reports-presentations/.

For further information, please contact:

CEO Seppo Orsila, m. +358 40 830 4671

IR Ulla Haapanen, m. +358 40 830 4676
Email: ir@modulight.com

Certified adviser: Danske Bank A/S, Finland Branch, m. +358 40 414 5358
 
modulight.com
@modulight, @orsila

Modulight in brief

Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.

Follow Modulight: modulight.com | X | LinkedIn | Facebook | YouTube | Instagram | #killcancer #laserfamily

Attachments

Modulight Annual Report 2023
Modulight Corporate Governance Statement 2023
Modulight Remuneration Report 2023

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden